Use of colloidal silica for the treatment of sickle-cell anaemia, malaria and exogenously induced leucopenias

US5753632A · kind A · utility

Inventors

• Alfred Schmidt · Seevetal, DE
• Emmanuel Bisse · Denzlingen, DE
• Heinrich Wieland · Giengen an der Brenz, DE

Key dates

• Filing date: Sep 21, 1995
• Grant date: May 19, 1998
• Expiry date: Sep 21, 2015

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The use of colloidal silica for the treatment of sickle-cell anaemia, malaria and exogenously induced leucopenias leads to a significant improvement in the condition of the patients.